CyBio AG’s 2006 revenues grew 8.2% to €15.5 million ($20.6 million). North American sales increased 18.0% to make up 45.4% of revenues, European sales rose 2.4% to represent 49.7% and Asian sales declined to 4.9% of revenues. Germany accounted for 21.6% of total sales. The instrument business accounted for approximately half of company revenues. In […]
Under a strategic alliance announced in February, VWR International’s BioSciences program will offer Tecan’s microarray instruments and microplate readers.
The National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), will be granting $23 million a year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance. The Centers of Excellence are located at the following institutions: St. Jude Children’s Hospital, UCLA, the […]
According to the Industrial Research Institute’s (IRI) 23rd annual “R&D Trends Forecast,” R&D spending will increase in 2007. IRI’s R&D index is determined by subtracting the percentage of companies that plan to decrease or maintain their R&D spending from the percentage of companies that plan to increase their spending by at least 5%. This index […]
This issue, IBO has made two changes to its Lab Equipment/Consumables Sales Index. Merck KGaA was removed from the Index, while Thermo Fisher Scientific’s Laboratory Products and Services segment was added. Fourth quarter sales for the new Lab Equipment/Consumables Index gained 11.9% to $769 million, while operating profits improved 15.5% to $200 million. Operating margin […]
Santa Clara, CA 4/6/07; La Jolla, CA 4/6/07—Agilent Technologies has signed a definitive agreement to purchase Stratagene for $10.94 per share of common stock, a 28% premium over Stratagene’s April 5 closing prices, or approximately $246.2 million in cash. Stratagene’s products include reagents and instruments for life science research and clinical diagnostics. “We see Stratagene’s […]
Venlo, The Netherlands 4/13/07—QIAGEN NV has agreed to acquire eGene, the maker of the HAD-GT12 Genetic Analyzer, an capillary electrophoresis–based system for DNA analysis in research and molecular diagnostics applications. QIAGEN North American Holdings will offer $0.65 in cash and 0.0416 common shares of QIAGEN stock per eGene share for an aggregate amount of approximately […]
Micronic BV introduced VolumeCheck for the determination of sample volumes in unsealed 96-well microplates, 96-tube racks and high-volume test tube racks. CyBio AG introduced the new-generation CyBi-Well vario, which allows liquid transfer from 25 nL to 250 µL. Tecan introduced the HID EVOlution Systems for the analysis of forensic DNA casework samples. It integrates Tecan’s […]
Automated liquid handling (ALH) is instrumental in drug discovery initiatives and has helped speed the workflow in life science research laboratories. Although growth in the ALH market is not what it used to be, the market continues to provide innovative advancements such as low-volume dispensing systems for key applications in drug discovery. There are several […]
In 1984, Applied Biosystems introduced the first DNA sequencer, revolutionizing genomic analysis. Amersham Biosciences (now GE Healthcare), Beckman Coulter and other companies followed, creating a market estimated at more than $800 million. The most widely used technology for DNA sequencing is a capillary electrophoresis–based (CE) system employing the Sanger method. Although chemistries and automation advances […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
